JAMES A HALIKAS, MD
Psychiatric at Park Central Ct, Naples, FL
License number
Florida ME0069324
Category
Psychiatric
Type
Addiction Medicine
License number
Florida ME0069324
Category
Psychiatric
Type
Addiction Psychiatry
License number
Florida ME0069324
Category
Osteopathic Medicine
Type
Family Medicine
License number
Florida ME0069324
Category
Osteopathic Medicine
Type
General Practice
License number
Florida ME0069324
Category
Osteopathic Medicine
Type
Addiction Medicine
License number
Florida ME69324
Category
Psychiatric
Type
Psychiatry
License number
Florida ME69324
Category
Psychiatric
Type
Geriatric Psychiatry
License number
Florida ME69324
Category
Psychiatric
Type
Child & Adolescent Psychiatry
License number
Florida ME69324
Category
Psychiatric
Type
Pain Medicine
Address
Address
5445 Park Central Ct, Naples, FL 34109
Phone
(239) 592-7535
(239) 592-5987 (Fax)
(239) 592-5987 (Fax)
Personal information
See more information about JAMES A HALIKAS at radaris.comName
Address
Phone
15425 Cedarwood Ln APT 104, Naples, FL 34110
783 Tramore Ln, Naples, FL 34108
11181 Health Park Blvd, Naples, FL 34110
15425 Cedarwood Ln #104, Naples, FL 34110
793 Tramore Ln, Naples, FL 34108
Organization information
See more information about JAMES A HALIKAS at bizstanding.comNaples Psychiatric & CNSLNG - James A Halikas MD
5445 Park Central Ct STE 1, Naples, FL 34109
Categories:
Alcohol & Drug Abuse Information & Treatment, Neurology Physicians & Surgeons, Physicians & Surgeons, ...
Site:
Phone:
(239) 592-7535 (Phone)
Products:
Adult A.D.D., Adult A.D.D.-Bipolar-Anxiety, Adult Attention Deficit Disorder, ...
Certifications:
Certified in Addiction Psychiatry
Additional:
Psychopharmacololgy, Remarkable New Office Medical, Champ - Prometa Protocols With Excellent Results in Just 3 Days, Stop Self-Medicating, New Patients Welcome
James Halikas, MD, LLC
5445 Park Central Ct, Naples, FL 34109
Registration:
Apr 5, 2013
State ID:
L13000052144
Business type:
Florida Limited Liability
Manager:
James A. Halikas (Manager)
Professional information
James A Halikas, Naples FL
Specialties:
Psychiatrist
Address:
5445 Park Central Ct, Naples, FL 34109
Education:
Duke University, School of Medicine - Doctor of Medicine
Barnes-Jewish Hospital - Residency - Psychiatry
Barnes-Jewish Hospital - Internship - Rotating
Barnes-Jewish Hospital - Residency - Psychiatry
Barnes-Jewish Hospital - Internship - Rotating
Board certifications:
American Board of Psychiatry and Neurology Certification in Psychiatry (Psychiatry and Neurology)
Method Of Controlling Alcohol Intake And Reversing Alcohol Effects
US Patent:
2006026, Nov 23, 2006
Filed:
May 23, 2005
Appl. No.:
11/134675
Inventors:
James Halikas - Naples FL, US
International Classification:
A61L 9/04
US Classification:
424045000
Abstract:
A method for controlling or reversing the alcohol intake in the non-alcohol dependent individual both before or during their alcohol imbibing. This is accomplished by self-administering a spray directed into sensitive mucosal vein endings of the individual. There are at least three technologies to accomplish the above noted task. The first one is a nasal spray which is directed into the nasal passage. The second spray is directed into the mouth of the individual so that the medication can be absorbed by the buccal mucosal membrane in the mouth of the individual. The third medicated spray technology is pulmonary inhaler aerosolization which is absorbed in the tissues of the lung. All of the above noted sprays by-pass the liver and the intestines. The medication, Flumazenil, is the medication used in any of these sprays to accomplish the desired effect.
Treatment For Neuro-Degenerative Disease By A Blood Cleansing System Using Monoclonal Antibodies
US Patent:
2005015, Jul 21, 2005
Filed:
Dec 9, 2004
Appl. No.:
11/007875
Inventors:
James Halikas - Naples FL, US
International Classification:
A61K039/395, C02F001/44
US Classification:
424140100, 210645000
Abstract:
Neuro-degenerative diseases such as Alzheimer's Disease with circulating molecules that pass through the Blood Brain Barrier which can generate a monoclonal antibodies specific to the offending circulating molecules are treated with an external blood cleansing system utilizing the monoclonal antibodies to extract the offending molecules.
Method Of Preventing Relapse In The Abstinent Substance Dependent Individual
US Patent:
2006017, Aug 3, 2006
Filed:
Feb 3, 2005
Appl. No.:
11/049067
Inventors:
James Halikas - Naples FL, US
International Classification:
A61K 31/5513
US Classification:
514221000
Abstract:
A method of preventing a relapse in the abstinent substance abuse dependent person. The method involves the use of the medication of Flumazenil in a nasal spray device and to teach the person to self-administer the medication by spraying the medication into the nasal passage whenever the need and the urge to relapse arises, thereby preventing relapse.